Logo image of RYAN

RYAN SPECIALTY HOLDINGS INC (RYAN) Stock Fundamental Analysis

NYSE:RYAN - New York Stock Exchange, Inc. - US78351F1075 - Common Stock - Currency: USD

67.4  -3.22 (-4.56%)

After market: 67.4 0 (0%)

Fundamental Rating

4

RYAN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 143 industry peers in the Insurance industry. There are concerns on the financial health of RYAN while its profitability can be described as average. RYAN is valued quite expensive, but it does show an excellent growth.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

RYAN had positive earnings in the past year.
In the past year RYAN had a positive cash flow from operations.
Each year in the past 5 years RYAN has been profitable.
Each year in the past 5 years RYAN had a positive operating cash flow.
RYAN Yearly Net Income VS EBIT VS OCF VS FCFRYAN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.15%, RYAN is in line with its industry, outperforming 40.56% of the companies in the same industry.
With a decent Return On Equity value of 17.62%, RYAN is doing good in the industry, outperforming 76.22% of the companies in the same industry.
With an excellent Return On Invested Capital value of 11.81%, RYAN belongs to the best of the industry, outperforming 96.50% of the companies in the same industry.
RYAN had an Average Return On Invested Capital over the past 3 years of 10.21%. This is significantly above the industry average of 4.47%.
The last Return On Invested Capital (11.81%) for RYAN is above the 3 year average (10.21%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 1.15%
ROE 17.62%
ROIC 11.81%
ROA(3y)0.93%
ROA(5y)1.1%
ROE(3y)12.97%
ROE(5y)16.02%
ROIC(3y)10.21%
ROIC(5y)9.27%
RYAN Yearly ROA, ROE, ROICRYAN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 20 40 60 80

1.3 Margins

The Profit Margin of RYAN (3.61%) is worse than 72.73% of its industry peers.
RYAN's Profit Margin has declined in the last couple of years.
RYAN has a better Operating Margin (23.65%) than 86.71% of its industry peers.
In the last couple of years the Operating Margin of RYAN has grown nicely.
Industry RankSector Rank
OM 23.65%
PM (TTM) 3.61%
GM N/A
OM growth 3Y6.77%
OM growth 5Y12.9%
PM growth 3Y-6.47%
PM growth 5Y-14.82%
GM growth 3YN/A
GM growth 5YN/A
RYAN Yearly Profit, Operating, Gross MarginsRYAN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 5 10 15 20

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so RYAN is still creating some value.
The number of shares outstanding for RYAN has been increased compared to 1 year ago.
RYAN has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, RYAN has a worse debt to assets ratio.
RYAN Yearly Shares OutstandingRYAN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
RYAN Yearly Total Debt VS Total AssetsRYAN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

RYAN has an Altman-Z score of 1.84. This is not the best score and indicates that RYAN is in the grey zone with still only limited risk for bankruptcy at the moment.
With an excellent Altman-Z score value of 1.84, RYAN belongs to the best of the industry, outperforming 91.61% of the companies in the same industry.
RYAN has a debt to FCF ratio of 7.02. This is a slightly negative value and a sign of low solvency as RYAN would need 7.02 years to pay back of all of its debts.
RYAN has a Debt to FCF ratio of 7.02. This is in the lower half of the industry: RYAN underperforms 69.23% of its industry peers.
A Debt/Equity ratio of 5.15 is on the high side and indicates that RYAN has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 5.15, RYAN is doing worse than 95.80% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 5.15
Debt/FCF 7.02
Altman-Z 1.84
ROIC/WACC1.41
WACC8.38%
RYAN Yearly LT Debt VS Equity VS FCFRYAN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

RYAN has a Current Ratio of 1.05. This is a normal value and indicates that RYAN is financially healthy and should not expect problems in meeting its short term obligations.
RYAN's Current ratio of 1.05 is fine compared to the rest of the industry. RYAN outperforms 79.02% of its industry peers.
RYAN has a Quick Ratio of 1.05. This is a normal value and indicates that RYAN is financially healthy and should not expect problems in meeting its short term obligations.
RYAN has a better Quick ratio (1.05) than 79.02% of its industry peers.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.05
RYAN Yearly Current Assets VS Current LiabilitesRYAN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

8

3. Growth

3.1 Past

RYAN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 29.71%, which is quite impressive.
Measured over the past years, RYAN shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -11.82% on average per year.
The Revenue has grown by 47.67% in the past year. This is a very strong growth!
RYAN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 26.88% yearly.
EPS 1Y (TTM)29.71%
EPS 3Y4.83%
EPS 5Y-11.82%
EPS Q2Q%28.57%
Revenue 1Y (TTM)47.67%
Revenue growth 3Y20.64%
Revenue growth 5Y26.88%
Sales Q2Q%24.52%

3.2 Future

The Earnings Per Share is expected to grow by 20.13% on average over the next years. This is a very strong growth
Based on estimates for the next years, RYAN will show a quite strong growth in Revenue. The Revenue will grow by 16.21% on average per year.
EPS Next Y19.32%
EPS Next 2Y21.41%
EPS Next 3Y21.58%
EPS Next 5Y20.13%
Revenue Next Year21.83%
Revenue Next 2Y19.04%
Revenue Next 3Y17.69%
Revenue Next 5Y16.21%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
RYAN Yearly Revenue VS EstimatesRYAN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 1B 2B 3B 4B 5B
RYAN Yearly EPS VS EstimatesRYAN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 1 2 3 4

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 37.65 indicates a quite expensive valuation of RYAN.
Based on the Price/Earnings ratio, RYAN is valued expensively inside the industry as 80.42% of the companies are valued cheaper.
RYAN's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 28.29.
With a Price/Forward Earnings ratio of 31.56, RYAN can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, RYAN is valued a bit more expensive than 76.92% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of RYAN to the average of the S&P500 Index (21.32), we can say RYAN is valued slightly more expensively.
Industry RankSector Rank
PE 37.65
Fwd PE 31.56
RYAN Price Earnings VS Forward Price EarningsRYAN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

RYAN's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. RYAN is more expensive than 64.34% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, RYAN is valued a bit more expensive than the industry average as 69.93% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 37.73
EV/EBITDA 23.78
RYAN Per share dataRYAN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
RYAN has a very decent profitability rating, which may justify a higher PE ratio.
RYAN's earnings are expected to grow with 21.58% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.95
PEG (5Y)N/A
EPS Next 2Y21.41%
EPS Next 3Y21.58%

0

5. Dividend

5.1 Amount

RYAN has a yearly dividend return of 0.64%, which is pretty low.
Compared to an average industry Dividend Yield of 3.28, RYAN is paying slightly less dividend.
With a Dividend Yield of 0.64, RYAN pays less dividend than the S&P500 average, which is at 2.51.
Industry RankSector Rank
Dividend Yield 0.64%

5.2 History

RYAN does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
RYAN Yearly Dividends per shareRYAN Yearly Dividends per shareYearly Dividends per share 2024 2025 0.2 0.4 0.6

5.3 Sustainability

RYAN pays out 72.53% of its income as dividend. This is not a sustainable payout ratio.
DP72.53%
EPS Next 2Y21.41%
EPS Next 3Y21.58%
RYAN Yearly Income VS Free CF VS DividendRYAN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M
RYAN Dividend Payout.RYAN Dividend Payout, showing the Payout Ratio.RYAN Dividend Payout.PayoutRetained Earnings

RYAN SPECIALTY HOLDINGS INC

NYSE:RYAN (4/21/2025, 5:05:01 PM)

After market: 67.4 0 (0%)

67.4

-3.22 (-4.56%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)02-20 2025-02-20/amc
Earnings (Next)05-01 2025-05-01/amc
Inst Owners81.59%
Inst Owner Change0.52%
Ins Owners13.84%
Ins Owner Change-4.92%
Market Cap17.65B
Analysts75
Price Target77.6 (15.13%)
Short Float %4.94%
Short Ratio5.17
Dividend
Industry RankSector Rank
Dividend Yield 0.64%
Yearly Dividend0.31
Dividend Growth(5Y)N/A
DP72.53%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-04 2025-03-04 (0.12)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-2.89%
Min EPS beat(2)-3.27%
Max EPS beat(2)-2.5%
EPS beat(4)1
Avg EPS beat(4)-1.48%
Min EPS beat(4)-3.27%
Max EPS beat(4)1.45%
EPS beat(8)3
Avg EPS beat(8)-0.38%
EPS beat(12)6
Avg EPS beat(12)0.73%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.27%
Min Revenue beat(2)-1.3%
Max Revenue beat(2)-1.24%
Revenue beat(4)0
Avg Revenue beat(4)-1.4%
Min Revenue beat(4)-1.63%
Max Revenue beat(4)-1.24%
Revenue beat(8)1
Avg Revenue beat(8)-0.62%
Revenue beat(12)3
Avg Revenue beat(12)-0.23%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.39%
PT rev (3m)-1.68%
EPS NQ rev (1m)-1.04%
EPS NQ rev (3m)-9.26%
EPS NY rev (1m)-5.51%
EPS NY rev (3m)-4.55%
Revenue NQ rev (1m)-0.47%
Revenue NQ rev (3m)0.59%
Revenue NY rev (1m)-0.22%
Revenue NY rev (3m)1.13%
Valuation
Industry RankSector Rank
PE 37.65
Fwd PE 31.56
P/S 5.75
P/FCF 37.73
P/OCF 34.29
P/B 28.12
P/tB N/A
EV/EBITDA 23.78
EPS(TTM)1.79
EY2.66%
EPS(NY)2.14
Fwd EY3.17%
FCF(TTM)1.79
FCFY2.65%
OCF(TTM)1.97
OCFY2.92%
SpS11.71
BVpS2.4
TBVpS-13.34
PEG (NY)1.95
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.15%
ROE 17.62%
ROCE 14.22%
ROIC 11.81%
ROICexc 13.21%
ROICexgc 137.5%
OM 23.65%
PM (TTM) 3.61%
GM N/A
FCFM 15.25%
ROA(3y)0.93%
ROA(5y)1.1%
ROE(3y)12.97%
ROE(5y)16.02%
ROIC(3y)10.21%
ROIC(5y)9.27%
ROICexc(3y)13.17%
ROICexc(5y)11.62%
ROICexgc(3y)93.16%
ROICexgc(5y)N/A
ROCE(3y)12.29%
ROCE(5y)11.17%
ROICexcg growth 3Y9.66%
ROICexcg growth 5Y-25.48%
ROICexc growth 3Y0.3%
ROICexc growth 5Y-1.24%
OM growth 3Y6.77%
OM growth 5Y12.9%
PM growth 3Y-6.47%
PM growth 5Y-14.82%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 5.15
Debt/FCF 7.02
Debt/EBITDA 3.62
Cap/Depr 28.04%
Cap/Sales 1.53%
Interest Coverage 5.3
Cash Conversion 57.64%
Profit Quality 422.96%
Current Ratio 1.05
Quick Ratio 1.05
Altman-Z 1.84
F-Score6
WACC8.38%
ROIC/WACC1.41
Cap/Depr(3y)24.87%
Cap/Depr(5y)82.79%
Cap/Sales(3y)1.54%
Cap/Sales(5y)6.2%
Profit Quality(3y)577.52%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.71%
EPS 3Y4.83%
EPS 5Y-11.82%
EPS Q2Q%28.57%
EPS Next Y19.32%
EPS Next 2Y21.41%
EPS Next 3Y21.58%
EPS Next 5Y20.13%
Revenue 1Y (TTM)47.67%
Revenue growth 3Y20.64%
Revenue growth 5Y26.88%
Sales Q2Q%24.52%
Revenue Next Year21.83%
Revenue Next 2Y19.04%
Revenue Next 3Y17.69%
Revenue Next 5Y16.21%
EBIT growth 1Y55.6%
EBIT growth 3Y28.81%
EBIT growth 5Y43.25%
EBIT Next Year54.4%
EBIT Next 3Y29.16%
EBIT Next 5Y23%
FCF growth 1Y4.57%
FCF growth 3YN/A
FCF growth 5Y27.04%
OCF growth 1Y7.89%
OCF growth 3Y23.48%
OCF growth 5Y28.06%